No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Enzychem Lifesciences Corporation, a pharmaceutical company, primarily dedicates itself to formulating oral, small-molecule therapies aimed at addressing urgent unmet medical needs for patients in South Korea suffering from conditions in oncology, metabolic diseases, and inflammatory disorders. Furthermore, the firm is actively developing innovative treatments utilizing its EC-18 technology platform to combat chemotherapy-induced neutropenia, oral mucositis triggered by chemoradiation therapy, and acute radiation syndrome. Founded in 1999, its headquarters are situated in Seoul, South Korea.
www.enzychem.comNo one on the platform currently holds 183490.KQ.
No tracked institution reports a position in 183490.KQ as of their last filing.
No one on the platform has traded 183490.KQ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 183490.KQEnzychem Lifesciences Corporation | $990.00 | -2.65% | $83.8B | — |
| 000220.KSYuyu Pharma, Inc. | $3815.00 | -0.39% | $60.1B | — |
| 000225.KSYuyu Pharma, Inc. | $3680.00 | -1.87% | $55.5B | — |
| 000227.KSYuyu Pharma, Inc. | $7740.00 | -0.26% | $57.5B | — |
| 000230.KSIldong Holdings Co., Ltd. | $6030.00 | +0.00% | $69.6B | — |
| 001360.KSSAMSUNG PHARM. Co., Ltd. | $1370.00 | -1.01% | $128.9B | — |
| 002720.KSKUKJE PHARMA Co., Ltd. | $3240.00 | -1.52% | $68.6B | — |
Source: Financial Modeling Prep · peers by sector/industry